Synthetic biology technologies make it possible to create just about anything sustainably – including plants and fungal bioactives. Synbio has become a disruptive force that a growing number of companies are leaning into, including plant cell tech startup and Ginkgo Bioworks spinoff Ayana Bio. At the helm of the company is Frank Jaksch, who previously spent over two decades leading publicly-traded ingredient company ChromaDex.
Researchers propose L-arginine blend to restore performance and relieve long Covid
from NutraIngredients.com
Winter Launch Pad
from NutraIngredients-USA.com
Science shorts: Latest studies on eye health, blood glucose and weight management
from NutraIngredients-Asia.com
Amai Proteins finalizing initial closing of $100m round as it gears up for launch of ‘designer’ sweet protein in 2023
from FoodNavigator-USA.com
Usana acquires revenue outside of Asia with protein bar manufacturer, supplement MLM
Coronavirus
NutraWomen Wednesday: Muriel Gonzalez, EVP, Chief Merchandising & Marketing Officer, The Vitamin Shoppe
The changing retail landscape
Study sheds light on how omega-3s may affect nitric oxide production
Omega-3
LC40 probiotic significantly reduces gastrointestinal infections in C-section infants
Probiotics
